Successfully reported this slideshow.
Your SlideShare is downloading. ×

OS16 - 3.2.d Epidemiological Parameters from Transmission Experiments: New Methods for Old Data - S. Gubbins

Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad

Check these out next

1 of 16 Ad

OS16 - 3.2.d Epidemiological Parameters from Transmission Experiments: New Methods for Old Data - S. Gubbins

Download to read offline

OS16 - Open Session 2016
Cascais, Portugal
26 - 28 /10/2016

EuFMD Sessions\Open Session\Archive-2018\Open 2016 Cascais- Portugal\PPT presentations\

OS16 - Open Session 2016
Cascais, Portugal
26 - 28 /10/2016

EuFMD Sessions\Open Session\Archive-2018\Open 2016 Cascais- Portugal\PPT presentations\

Advertisement
Advertisement

More Related Content

Slideshows for you (9)

Similar to OS16 - 3.2.d Epidemiological Parameters from Transmission Experiments: New Methods for Old Data - S. Gubbins (20)

Advertisement

More from EuFMD (20)

Recently uploaded (20)

Advertisement

OS16 - 3.2.d Epidemiological Parameters from Transmission Experiments: New Methods for Old Data - S. Gubbins

  1. 1. European Commission for the Control of Foot-and-Mouth Disease Open Session of the EuFMD - Cascais –Portugal 26-28 October 2016 Epidemiological parameters from transmission experiments: new methods for old data Simon Gubbins, David Schley & Ben Hu Transmission Biology Group The Pirbright Institute
  2. 2. European Commission for the Control of Foot-and-Mouth Disease Background • Transmission experiments are commonly used in foot-and- mouth disease research • They are used to estimate: – transmission rates – basic reproduction number (R0) – latent, infectious and incubation periods – vaccine effectiveness
  3. 3. European Commission for the Control of Foot-and-Mouth Disease Experimental design • Most transmission experiments follow a similar design ... C1 C1 inoculate a number of donors C1 C1 C2 C2 introduce a number of naïve recipients C1 C1 C2 C2 observe the outcome: clinical virological immunological
  4. 4. European Commission for the Control of Foot-and-Mouth Disease Features of the experiments • We don’t directly observe what we’re interested in! – infection times – latent periods – infectious periods (typically rely on proxy measures) • Most commonly used methods for analysing transmission experiments (final size; generalized linear model) have to make assumptions to overcome these features
  5. 5. European Commission for the Control of Foot-and-Mouth Disease Bayesian methods: a better approach? • Using Bayesian methods allows us to avoid most assumptions • Allows us to draw inferences about unobserved processes (data augmentation): – infection times – latent and infectious periods • Allows us to incorporate data from previous experiments (priors)
  6. 6. European Commission for the Control of Foot-and-Mouth Disease Example 1: FMDV in lambs • Follows the generic experimental design Data from Orsel et al. (2007) Vaccine 25, 2673-2679 parameter previous Bayes R0 1.14 (0.3, 3.3) 1.45 (0.33, 3.08) mean latent period (days) inoculated - 1.12 (0.68, 1.68) contact - 1.50 (0.16, 2.84) mean infectious period (days) 21.1 (10.6, 42.1) 15.4 (11.0, 21.4)
  7. 7. European Commission for the Control of Foot-and-Mouth Disease Example 2: FMDV in pigs • Two experimental designs – results analysed together Data from Orsel et al. (2007) Vaccine 25, 6381-6391
  8. 8. European Commission for the Control of Foot-and-Mouth Disease Example 2 (ctd): FMDV in pigs parameter previous Bayes R0 ∞ 8.54 (4.41, 14.9) transmission rate 6.84 (3.17, 14.8) 1.51 (0.76, 2.55) mean latent period (days) inoculated - 0.97 (0.40, 1.67) contact - 0.14 (0.01, 0.33) mean infectious period (days) - 4.74 (3.83, 5.86)
  9. 9. European Commission for the Control of Foot-and-Mouth Disease Example 2 (ctd): FMDV in pigs • Vaccination significantly reduces R0, but not to below 1 – previous analyses could not identify a significant effect of vaccination
  10. 10. European Commission for the Control of Foot-and-Mouth Disease When is an animal infectious? • This is critical to inferring transmission dynamics • Often inferred from proxy measures – detection of virus in blood, probang, nasal swabs ... • Can we infer infectiousness directly? – and, hence, identify a robust proxy measure
  11. 11. European Commission for the Control of Foot-and-Mouth Disease Experimental design Day 0 Day 2 Day 4 Day 6 Day 8 Virological data: blood, nasal swabs, probang Clinical signs Transmission Data from Charleston et al. (2011) Science 332, 726-729
  12. 12. European Commission for the Control of Foot-and-Mouth Disease Quantifying infectiousness • We analyse the data assuming infectiousness changes continuously over time – cf. latent and infectious periods • The approach also – links infectiousness and onset of clinical signs – allows for individual variation in infectiousness • Implemented in a Bayesian framework
  13. 13. European Commission for the Control of Foot-and-Mouth Disease
  14. 14. European Commission for the Control of Foot-and-Mouth Disease Does this matter? • Choice of proxy measure influences conclusions about: – basic reproduction number – generation time – effectiveness of reactive control measures • These effects scale up to the herd level
  15. 15. European Commission for the Control of Foot-and-Mouth Disease Conclusions • Bayesian methods facilitate analysis of transmission experiments – reduce the number of assumptions to be made – obtain estimates where classical methods fail • Generate insights into transmission processes – dynamics of infectiousness – who infects whom • Quantification of uncertainty in epidemiological parameters – essential when incorporating estimates in regional scale models of spread and control
  16. 16. European Commission for the Control of Foot-and-Mouth Disease Acknowledgements • Everyone whose data we’ve stolen • José Gonzáles (WBR Lelystad) • Bryan Charleston (Pirbright) • Mark Woolhouse (Edinburgh) • Mike Tildesley (Warwick) • Leon Danon (Bristol)

×